Palisade Bio Inc. (PALI)
NASDAQ: PALI
· Real-Time Price · USD
0.65
0.04 (6.04%)
At close: Jun 17, 2025, 3:27 PM
6.04% (1D)
| Bid | 0.64 |
| Market Cap | 3.13M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.14M |
| EPS (ttm) | -6.07 |
| PE Ratio (ttm) | -0.11 |
| Forward PE | -0.68 |
| Analyst | Buy |
| Ask | 0.65 |
| Volume | 161,396 |
| Avg. Volume (20D) | 287,833 |
| Open | 0.64 |
| Previous Close | 0.61 |
| Day's Range | 0.61 - 0.67 |
| 52-Week Range | 0.60 - 5.15 |
| Beta | 1.34 |
About PALI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PALI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PALI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+6.07%
Palisade Bio shares are trading lower after the co...
Unlock content with
Pro Subscription
6 months ago
+68.57%
Palisade Bio shares are trading higher. The company announced the pricing of a $5 million underwritten public offering.
